deltatrials
Unknown OBSERVATIONAL NCT05262647

18F-FAPI PET in the Diagnosis of Liver Fibrosis

A Prospective Study for Effectiveness of 18F-FAPI PET in the Diagnosis of Liver Fibrosis: Comparison With Liver Biopsy

Sponsor: The Affiliated Hospital of Qingdao University

Conditions FAP Liver Fibrosis Positron Emission Tomography
Interventions 18F-FAPI
Updated 4 times since 2022 Last updated: Feb 21, 2022 Started: Dec 12, 2021 Primary completion: Dec 1, 2022 Completion: Dec 1, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05262647, this observational or N/A phase trial focuses on FAP and Liver Fibrosis and remains ongoing. Sponsored by The Affiliated Hospital of Qingdao University, it has been updated 4 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Apr 2022 – ~Mar 2024 · 23 months · monthly snapshotRecruiting~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshotUnknown

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown Status → Unknown

  3. Mar 2024 — Jul 2024 [monthly]

    Unknown Status

    Status: Recruiting → Unknown Status

  4. Apr 2022 — Mar 2024 [monthly]

    Recruiting

    First recorded

Dec 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • The Affiliated Hospital of Qingdao University
Data source: The Affiliated Hospital of Qingdao University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations